HEMP STOCK STUNNER: This is How to Play the CBD Buying Spree

https://www.wealthresearchgroup.com/wp-content/uploads/2019/01/cannabis-cart.jpg

Today’s best bets in the legalized cannabis market aren’t what the corporate media has been reporting on, nor are they the overpriced stocks that retail investors have already bid up to nosebleed levels. Let’s face it: outside-the-box thinking is needed in 2019 if you’re going to see the really big gains in hemp stocks.

The idea is to research market and consumer trends and anticipate the next move with a position in a small stock that’s likely to become expensive soon. For instance, you may have noticed that companies like Coca-Cola and Keurig Dr. Pepper Inc. have been promoting healthier drink options to meet the growing consumer demand for more mindful beverage options.

You really can’t blame these companies for making changes, as a multi-decade shift away from unhealthy, sugary drink consumption has put beverage mega-corporations under tremendous pressure:

Courtesy: Dynamic Wealth Research, Yahoo Finance, Twitter

Faced with declining revenues, these companies have been forced to evolve and move with the markets in order to survive. Millennials, who are now America’s largest demographic age group, have different preferences than past generations did. They prefer healthier drinks, and they’re also in favor of CBD-infused food and drink products because of their known anti-anxiety and anti-inflammatory properties.

CBD comes from the hemp plant, and the entire hemp industry received a gigantic boost when the U.S. Congress and President approved the Farm Bill in December. It was a watershed moment because the Farm Bill legalized hemp, and therefore CBD products, on a federal level.

One company that has benefited from all of these trends and developments is Koios Beverage Corp. (CSE: KBEV, OTC: KBEVF), which sells a very popular line of healthy beverages that include nootropics (natural brain-enhancing supplements and other substances). Koios has a robust distribution network of over 2,000 physical retail locations (including GNC, 7-11, and Gold’s Gym), in addition to Amazon and their own Website, MentalTitan.com.

Courtesy: Koios Beverage Corp.

Not only does Koios have proprietary nootropic formulas for their beverages, but they also have a line of CBD-infused drinks. Infused with cannabidiols derived from hemp plants and the company’s nootropic stack, this line of quality beverages is released by Cannavated, Koios’ subsidiary in partnership with Keef Brands.

And while domestic sales have been strong, Koios is also looking to expand internationally and has already initiated direct shipping to Canada. Koios CEO Chris Miller notes that “We have particularly been seeing increased demand for our products in Canada, and are happy to be able to meet that demand with our global shipping program now. Our mission is to bring the benefits of nootropic supplements to the world.

It’s a mission that’s beneficial to consumers, distributors, and investors of KBEV/KBEVF stock. With the long-awaited Farm Bill now in effect and hemp fully legalized throughout North America, Koios Beverage Corp. is on the forefront of an unstoppable movement that’s enriching investors and changing the world for the better.

Best Regards,

Lior Gantz
President, WealthResearchGroup.com

Legal Notice:

This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. Never base any decision off of our emails. wealthresearchgroup stock profiles are intended to be stock ideas, not recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. We have entered into an agreement for three hundred thousand dollars and five hundred thousand options paid for directly by koios beverage. We have also purchased shares and are long koios beverage. Please use our site as a place to get ideas. Never make an investment decision off of anything we say. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.

Please read our full disclaimer at WealthResearchGroup.com/disclaimer

Original Article Available HERE

Originally posted here: https://steemit.com/cannabis/@wealthresearch/hemp-stock-stunner-this-is-how-to-play-the-cbd-buying-spree-20190427t165427243z